PRESS RELEASE published on 07/04/2025 at 15:06, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. disclosed a 3.46% stake in Dalata Hotel Group plc, acquiring 17,665 ordinary shares at 6.47 EUR and 795 shares at 6.48 EUR on 03 July 2025 Acquisition Ordinary Shares The Vanguard Group Inc. Dalata Hotel Group Plc Stake Disclosure
BRIEF published on 07/04/2025 at 15:06, 1 year 2 months ago The Vanguard Group Discloses Position in Deliveroo plc Form 8.3 Takeover Code Vanguard Group Deliveroo PLC Shareholding
BRIEF published on 07/04/2025 at 15:05, 1 year 2 months ago The Vanguard Group Discloses Position in Dowlais Group plc Takeover Code Securities Disclosure Vanguard Group Shareholding Dowlais Group
PRESS RELEASE published on 07/04/2025 at 15:05, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.48% stake in Mural Oncology plc. Details of securities holdings and recent dealings provided Vanguard Group Stake Disclosure Securities Holdings Mural Oncology Plc Recent Dealings
BRIEF published on 07/04/2025 at 15:04, 1 year 2 months ago The Vanguard Group Discloses Position in Tritax Big Box REIT Form 8.3 Takeover Code Securities Disclosure Vanguard Group Tritax Big Box REIT
PRESS RELEASE published on 07/04/2025 at 15:04, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.32% stake in Greencore Group plc. Additional disclosure for Bakkavor Group plc. Details in Form 8.3 Form 8.3 The Vanguard Group Stake Disclosure Greencore Group Plc Bakkavor Group Plc
BRIEF published on 07/04/2025 at 15:03, 1 year 2 months ago Vanguard Discloses Position in Bakkavor Group Disclosure Takeover Code Vanguard Group Shareholding Bakkavor Group
PRESS RELEASE published on 07/04/2025 at 15:03, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses 5.64% stake in Primary Health Properties plc. Also making disclosures for Assura plc. Details of positions and dealings provided The Vanguard Group Stake Disclosures Assura Plc Primary Health Properties Plc
BRIEF published on 07/04/2025 at 15:03, 1 year 2 months ago The Vanguard Group, Inc. Discloses Position in Unite Group plc Securities Disclosure Investment Vanguard Group Unite Group
PRESS RELEASE published on 07/04/2025 at 15:02, 1 year 2 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses 5.71% ownership in Assura plc with 185,531,127 shares. Also making disclosures for Primary Health Properties plc. Dealings include purchasing 14,983 10p ordinary shares at 0.50 GBP per unit Stock Purchase Vanguard Group Ownership Disclosure Financial Disclosure Assura Plc
Published on 09/11/2026 at 04:00, 4 hours 2 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 9 hours 37 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 16 hours 42 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 17 hours 2 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 07:30, 31 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 7 hours 56 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 9 hours 22 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 51 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 1 hour 2 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 12 hours 32 minutes ago Availability of the 2026 Interim Financial Report
